Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Theres no direct head-to-head trial, but Mounjaro outperformed injectable semaglutide (which delivers higher semaglutide levels than Rybelsus) in the SURPASS-2 trial
The TGA has urged prescribers not to initiate new patients on Ozempic unless there are no suitable alternatives or theres a compelling medical reason to do so, and has asked pharmacists to prioritise patients who are already stabilised on the medication
Patients should consult their pharmacist or provider if dose adjustments are needed
Once reconstituted, stability drops to 28 days under optimal conditions
Report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Are Willow's GLP-1 medications FDA-approved
US$ 22.31
US$ 25.41
US$ 22.30
US$ 21.87
